The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels.
The conference helps facilitate face to face meetings between companies and investors based on a common fit (indication, technology & stage of development) which promotes compelling conversations, facilitating the development of qualified investor to entrepreneur relationships. The RESI Conference also serves as an excellent opportunity for large pharma/ medtech companies and service providers to connect with attending companies and investors representing their portfolio companies.
10% discount on registration for United Life Sciences (Bionow, BioPartner, BIA, MediWales, One Nucleus) and OBN members.